| Line Item | 2026-04-24 | Y/Y |
|---|---|---|
| Revenue | $6.24B | +5.6% |
| Cost of Revenue | $2.03B | +3.4% |
| Gross Profit | $4.90B | +6.2% |
| R&D Expense | $991.0M | -2.1% |
| SG&A Expense | $344.0M | +10.6% |
| Operating Income | $1.67B | +25.2% |
| Pre-tax Income | $1.65B | +19.2% |
| Income Tax | $372.0M | +88.8% |
| Net Income | $1.28B |
| Line Item | 2026-04-24 | Y/Y |
|---|---|---|
| Cash & Equivalents | $2.07B | -24.5% |
| Short-term Investments | $1.51B | +37.1% |
| Accounts Receivable | $1.29B | +3.2% |
| Inventory | $198.0M | +6.5% |
| Current Assets | $5.78B | -1.3% |
| Total Assets | $10.74B | -0.7% |
| Current Liabilities | $4.02B | -13.7% |
| Line Item | 2026-04-24 | Y/Y |
|---|---|---|
| Operating Cash Flow | $2.07B | +37.3% |
| Capital Expenditures | $198.0M | +17.9% |
| Investing Cash Flow | -$595.0M | -504.8% |
| Financing Cash Flow | -$2.15B | -159.3% |
| Free Cash Flow | $1.87B | +39.7% |
| +7.6% |
| EPS (Basic) | $6.41 | +10.3% |
| EPS (Diluted) | $6.35 | +12.0% |
| Long-term Debt |
| $2.49B |
| -23.1% |
| Total Liabilities | $9.39B | -4.0% |
| Stockholders' Equity | $1.35B | +29.9% |